It is generally agreed that the best time to involve a biostatistician in a clinical study is at its inception. This allows the biostatistician to support with common biostatistics challenges in clinical research: understanding the study design and making suggestions on hypothesis testing and analysis.
CROS NT has performed statistical analysis and reporting activities for thousands of studies in a variety of therapeutic areas, in all phases of drug development and medical device trials.